HeartSciences Inc. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q2 2021 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
HeartSciences Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q2 2021 to Q2 2025.
  • HeartSciences Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending July 31, 2025 was -$1.95M, a 3.24% increase year-over-year.
  • HeartSciences Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$7.41M, a 22.1% decline from 2023.
  • HeartSciences Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$6.07M, a 5.14% decline from 2022.
  • HeartSciences Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$5.77M, a 58.4% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$1.95M +$65.4K +3.24% May 1, 2025 Jul 31, 2025 10-Q 2025-09-11
Q2 2024 -$2.02M -$614K -43.8% May 1, 2024 Jul 31, 2024 10-Q 2025-09-11
Q2 2023 -$1.4M +$407K +22.5% May 1, 2023 Jul 31, 2023 10-Q 2024-09-12
Q2 2022 -$1.81M -$1.09M -153% May 1, 2022 Jul 31, 2022 10-Q 2023-09-14
Q2 2021 -$717K May 1, 2021 Jul 31, 2021 10-Q 2022-09-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.